These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 25384187)

  • 1. Drugging sphingosine kinases.
    Santos WL; Lynch KR
    ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building a better sphingosine kinase-1 inhibitor.
    Lynch KR
    Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase inhibitors: A patent review.
    Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
    Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sphingosine kinase 1 and tumor].
    Zhang CX; He HW; Shao RG
    Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
    Hait NC; Oskeritzian CA; Paugh SW; Milstien S; Spiegel S
    Biochim Biophys Acta; 2006 Dec; 1758(12):2016-26. PubMed ID: 16996023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
    Plano D; Amin S; Sharma AK
    J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.
    Magli E; Corvino A; Fiorino F; Frecentese F; Perissutti E; Saccone I; Santagada V; Caliendo G; Severino B
    Curr Pharm Des; 2019; 25(9):956-968. PubMed ID: 30947653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
    Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
    Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.
    Zhao Y; Kalari SK; Usatyuk PV; Gorshkova I; He D; Watkins T; Brindley DN; Sun C; Bittman R; Garcia JG; Berdyshev EV; Natarajan V
    J Biol Chem; 2007 May; 282(19):14165-77. PubMed ID: 17379599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure guided design of a series of sphingosine kinase (SphK) inhibitors.
    Gustin DJ; Li Y; Brown ML; Min X; Schmitt MJ; Wanska M; Wang X; Connors R; Johnstone S; Cardozo M; Cheng AC; Jeffries S; Franks B; Li S; Shen S; Wong M; Wesche H; Xu G; Carlson TJ; Plant M; Morgenstern K; Rex K; Schmitt J; Coxon A; Walker N; Kayser F; Wang Z
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4608-16. PubMed ID: 23845219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
    Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
    J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simple and robust assay to screen for inhibitors of sphingosine kinases.
    Togame H; Dodo R; Inaoka T; Reinemer P
    Assay Drug Dev Technol; 2007 Apr; 5(2):215-23. PubMed ID: 17477830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
    Ueda N
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
    Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
    J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.
    Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y
    Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid assay for assessment of sphingosine kinase inhibitors and substrates.
    Kharel Y; Mathews TP; Kennedy AJ; Houck JD; Macdonald TL; Lynch KR
    Anal Biochem; 2011 Apr; 411(2):230-5. PubMed ID: 21216217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
    Serrano-Sanchez M; Tanfin Z; Leiber D
    Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.